Explore our featured news items here. Subscribe to stay informed of all information shared and published by OHC.

Sponsor appreciation:

You’re invited to explore and join Physician Factor, a knowledge exchange network is a dedicated portal for physicians seeking opportunities to contribute their expertise and input in exchange for compensation and supplemental income.

You can search articles using your own keywords or the following tags: Lung Cancer | Breast Cancer | Drugs and Therapies | Cancer General

THIO Followed by Cemiplimab Shows Early Promise in Advanced NSCLC
OHC Editor OHC Editor

THIO Followed by Cemiplimab Shows Early Promise in Advanced NSCLC

The sequential combination of THIO (6-thio-2’-deoxyguanosine) and cemiplimab (Libtayo) provided a progression-free survival (PFS) benefit in the first 2 patients with advanced non–small cell lung cancer (NSCLC) enrolled to the part A safety lead-in portion of the phase 2 THIO-101 trial (NCT05208944).

Read More
Risk Factors for Nasopharyngeal Cancer
OHC Editor OHC Editor

Risk Factors for Nasopharyngeal Cancer

A risk factor is anything that raises a person’s chance of getting a disease such as cancer. Different cancers have different risk factors. Some risk factors, like smoking or diet, can be changed. Others, like a person's age or family history, can’t be changed. But risk factors don’t tell us everything. Having a risk factor, or even many risk factors, does not mean that you will get the disease. And many people who get the disease may have few or no known risk factors. This article spotlights some of the risk factors that make a person more likely to develop nasopharyngeal cancer (NPC).

Read More